MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/08998280.2025.2487381

Медицинская библиотека · Proceedings (Baylor University. Medical Center) · 2025

Refractory cutaneous pseudolymphoma treated with tapinarof.

Kichena Shravya, Limmer Emily, Kivelevitch Dario

Клинический случайСтатьяПеревод пока не подготовлен

Аннотация

Cutaneous pseudolymphoma (CPL) is a reactive polyclonal T- or B-cell lymphoproliferative process that histopathologically and/or clinically imitates cutaneous lymphoma. We report the case of a 62-year-old woman with a poorly defined, erythematous plaque with papules on the dorsal nose that had been present for years. This lesion was biopsied as an atypical T-cell infiltrate and was clinically diagnosed as a pseudolymphoma. After unsuccessful treatments with mometasone and tacrolimus, the patient was started on tapinarof cream 1%. After 10 months of treatment, there was clinical improvement of the plaque and papules with only slight residual erythema. Further studies and reports will help elucidate the role of tapinarof as a therapeutic option for pseudolymphoma. Based on its safety profile and promising results in other inflammatory and hyperproliferative disorders, it could be considered in refractory cases.

Для цитирования: Kichena Shravya, Limmer Emily, Kivelevitch Dario. Refractory cutaneous pseudolymphoma treated with tapinarof.. Proceedings (Baylor University. Medical Center). 2025. DOI: 10.1080/08998280.2025.2487381.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.